Acute Exacerbations of COPD

Asthma and COPD

Volumn , Issue , 2009, Pages 837-845

  Wedzicha, Jadwiga A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882887495     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374001-4.00067-5     Document Type: Chapter

References (72)

1. Wedzicha JA, Seemungal TAR COPD exacerbations: Defining their cause and prevention. Lancet 2007, 370:786-796.
2. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 151:1418-1422.
3. Bhowmik A, Seemungal TAR, Sapsford RJ, Wedzicha JA Relation of sputum inflammatory markers to symptoms and physiological changes at COPD exacerbations. Thorax 2000, 55:114-200.
4. Donaldson GC, Seemungal T, Jeffries DJ, Wedzicha JA Effect of environmental temperature on symptoms, lung function and mortality in COPD patients. Eur Respir J 1999, 13:844-849.
5. Anthonisen NRJ, Manfreda CPW, Warren ES, Hershfield GKM, Harding, Nelson NA Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987, 106:120-196.
6. Okubadejo AA, Jones PW, Wedzicha JA Quality of life in patients with COPD and severe hypoxaemia. Thorax 1996, 51:44-47.
7. Okubadejo AA, O'Shea L, Jones PW, Wedzicha JA Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long term oxygen therapy. Eur Respir J 1997, 10:1555-1572.
8. Ball P, Harris JM, Lowson D, Tillotson G, Wilson R Acute infective exacerbations of chronic bronchitis. Q J Med 1995, 88:61-68.
9. Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:1608-1613.
10. Reddel HS, Ware S, Marks G, Salome C, Jenkins C, Woolcock A Differences between asthma exacerbations and poor asthma control. Lancet 1999, 353:364-369.
11. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma. Am J Respir Crit Care Med 1999, 160:594-599.
12. Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002, 57:137-141.
13. Perera WR, Hurst JR, Wilkinson TMA, Sapsford RJ, Müllerova H, Donaldson GC, Wedzicha JA Inflammatory changes and recurrence at COPD exacerbations. Eur Respir J 2007, 29:527-534.
14. Hurst JR, Perera WR, Wilkinson TMA, Donaldson GC, Wedzicha JA Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:71-78.
15. Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994, 150:1646-1652.
16. Qiu Y, Zhu J, Bandi V, et al. Biopsy neutrophilia, neutrophil chemokin and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 168:968-975.
17. Biernacki W, Kharitonov SA, Barnes PJ Increased leukotriene B4 and 8-isprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003, 58:294-298.
18. Donaldson GC, Seemungal TAR, Patel IS, Lloyd-Owen SS, Bhowmik A, Wilkinson TMA, Hurst JR, Wilks M, MacCallum PK, Wedzicha JA Airway and systemic inflammation and decline in lung function, in chronic obstructive pulmonary disease. Chest 2005, 128:1995-2004.
19. Seemungal TAR, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, MacCallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA Respiratory viruses, symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:1618-1623.
20. Anderson HR, Limb ES, Bland JM, Ponce de Leon A, Strachan DP, Bower JS Health effects of an air pollution episode in London, December 1991. Thorax 1995, 50:1188-1193.
21. Linaker CH, Coggon D, Holgate ST, et al. Personal exposure to nitrogen dioxide and risk of airflow obstruction in asthmatic children with upper respiratory infection. Thorax 2000, 55:930-933.
22. Seemungal TAR, Harper -Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2000, 16:677-683.
23. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: A case-control study. Thorax 2003, 58:37-42.
24. Greenberg SB, Allen M, Wilson J, Atmar RL Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162:167-173.
25. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of the role of viral infections in exacerbations of asthma in 911 year old children. BMJ 1995, 310:1225-1229.
26. Falsey AR, Formica MA, Hennessey PA, et al. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:639-643.
27. Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA Respiratory syncytial virus, airway inflammation and FEV1 decline in patients with COPD. Am J Respir Crit Care Med 2006, 173:871-876.
28. Sapey E, Stockley RA COPD exacerbations 2: Aetiology. Thorax 2006, 61:250-258.
29. Wilkinson TMA, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA Interactions between lower airway bacterial and rhinoviral infection at exacerbations of chronic obstructive pulmonary disease. Chest 2006, 129:317-324.
30. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, Issue 2. Art. No.: CD004403. DOI: 10.1002/14651858.CD004403.pub2.
31. Sethi S, Evans N, Grant BJ, Murphy TF New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465-471.
32. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006, 173:1114-1121.
33. Blasi F, Damato S, Consentini R, et al. C. Pneumoniae and chronic bronchitis: Association with severity and bacterial clearance following treatment. Thorax 2002, 57:672.
34. Seemungal TAR, Wedzicha JA, MacCallum PK, Johnston SL, Lambert PA C. Pneumoniae and COPD exacerbation. Thorax 2002, 57:1087-1088.
35. Belman MJ, Botnick WC, Shin JW Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 153:967-975.
36. Braun SR, McKenzie WN, Copeland C, Knight L, Ellersieck M A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med 1989, 149:544-547.
37. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. Chest 1994, 105:1411-1419. Combivent Inhalation Aerosol Study Group.
38. Rebuck AS, Chapman KR, Abboud R, Pare PD, Kreisman H, Wolkove N, Vickerson F Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 1987, 82:59-64.
39. Rice KL, Leatherman JW, Duane PG, Snyder LS, Harmon KR, Abel J, Niewoehner DE Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. Ann Intern Med 1987, 107:305-309.
40. Duffy N, Walker P, Diamantea F, Calverley PMA, Davies L Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial. Thorax 2005, 60:713-717.
41. Callahan CM, Cittus RS, Katz BP Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: A meta-analysis. Ann Intern Med 1991, 114:216-223.
42. Keatings VM, Jatakanon A, Worsdell Y, Barnes PJ Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997, 155:542-548.
43. Culpitt SV, Maziak W, Loukidis S, et al. Effects of high dose inhaled steroids on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:1635-1639.
44. Albert RK, Martin TR, Lewis SW Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980, 92:753-758.
45. Emerman CL, Connors AF, Lukens TW, May ME, Effron D A randomised controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of chronic obstructive pulmonary disease. Chest 1989, 95:563-567.
46. Bullard MJ, Liaw SJ, Tsai YH, Min HP Early corticosteroid use in acute exacerbations of chronic airflow limitation. Am J Emerg Med 1996, 14:139-143.
47. Murata GH, Gorby MS, Chick TW, Halperin AK Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD. Chest 1990, 98:845-849.
48. Thompson WH, Nielson CP, Carvalho P, et al. Controlled trial of oral prednisolone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996, 154:407-412.
49. Davies L, Angus RM, Calverley PMA Oral corticosteroids in patients admitted to hospital with exacerbations of chronnic obstructive pulmonary disease: A prospective randomised controlled trial. Lancet 1999, 354:456-460.
50. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstuctive pulmonary disease. N Engl J Med 1999, 340:1941-1947.
51. Sachs APE, Koeter GH, Groenier KH, Van der Waaij D, Schiphuis J, Meyboom-de Jong B Changes in symptoms, peak expiratory flow and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 1995, 50:758-763.
52. Moser KM, Luchsinger PC, Adamson JS, McMahon SM, Schlueter DP, Spivack M, Weg JG Respiratory stimulation with intravenous doxapram in respiratory failure. N Engl J Med 1973, 288:427-431.
53. Angus RM, Ahmed AA, Fenwick LJ, Peacock AJ Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease. Thorax 1996, 51:1048-1050.
54. Bott J, Carroll MP, Conway JH, Keilty SEJ, Ward EM, Brown AM, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993, 341:1555-1557.
55. Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS Randomized prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995, 151:1799-1806.
56. Brochard L, Mancebo J, Wysocki M, Lofaso M, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995, 333:817-822.
57. Plant PK, Owen JL, Elliott MW A multicentre randomised controlled trial of the early use of non-invasive ventilation foracute exacerbations of chronic obstructive pulmonary disease on general respiratory wards. Lancet 2000, 355:1931-1935.
58. Ambrosino N, Foglio K, Rubini F, Clini E, Nava S, Vitacca M Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: Correlates for success. Thorax 1995, 50:755-757.
59. Brown JS, Meecham Jones DJ, Mikelsons C, Paul EA, Wedzicha JA Outcome of nasal intermittent positive pressure ventilation when used for acute-on-chronic respiratory failure on a general respiratory ward. J R Coll Physicians Lond 1998, 32:219-224.
60. Morretti M, Cilione C, Tampieri A, et al. Incidence and causes of non-invasive mechanical ventilation failure after initial success. Thorax 2000, 55:819-825.
61. Gravil JH, Al-Rawas OA, Cotton MM, et al. Home treatment of exacerbations of COPD by an acute respiratory assessment service. Lancet 1998, 351:1853-1855.
62. Cotton MM, Bucknall CE, Dagg KD, et al. Early discharge for patients with exacerbations of COPD: A randomised controlled trial. Thorax 2000, 55:902-906.
63. Skwarska E, Cohen G, Skwarski KM, et al. A randomised controlled trial of supported discharge in patients with exacerbations of COPD. Thorax 2000, 55:907-912.
64. Nichol KL, Baken L, Nelson A Relation between influenza vaccination and out patient visits, hospitalisation and mortality in elderly patients with chronic lung disease. Ann Intern Med 1999, 130:397-403.
65. Collet JP, Shapiro S, Ernst P, Renzi P, Ducruet T, Robinson A, et al. Effect of an immunostimulating agent on acute exacerbations and hospitalization in COPD patients. Am J Respir Crit Care Med 1997, 156:1719-1724.
66. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775-789.
67. Vincken W, van Noord JA, Greefhorst APM Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002, 19:209-216.
68. Casaburi R, Mahler DA, Jones PA, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002, 19:217-224.
69. Niewoehner DE, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once daily inhaled anticholinergic bronchodilator: A randomised trial. Ann Intern Med 2005, 143:317-326.
70. Powrie DJ, Wilkinson TMA, Donaldson GC, Jones P, Scrine K, Viel K, Kesten S, Wedzicha JA Effect of tiotropium on inflammation and exacerbations in chronic obstructive pulmonary disease. Eur Respir J 2007, 30:472-478.
71. Wedzicha JA, Calverley PMA, Seemungal TA, Hagan G, Ansari Z, Stockley RA The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide. Am J Respir Crit Care Med 2008, 177:19-26. for the INSPIRE Investigators.
72. Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Rad J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, Fitzgerald M Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial. Ann Intern Med 2007, 146:545-555.